- Published on
Infectious Disease and Microbiology – Conidiobolus Species
Overview
Conidiobolus coronatus is an uncommon filamentous fungus (mold) that primarily causes a chronic granulomatous infection of the nasal and facial subcutaneous tissues. The characteristic disease is called entomophthoromycosis conidiobolae, also known as conidiobolomycosis.
Microbiologic Characteristics
Conidiobolus coronatus is a filamentous fungus with broad hyphae containing relatively few septa. Infection typically produces a chronic granulomatous tissue response rather than the rapidly invasive necrosis characteristic of some other molds.
Epidemiology
The organism is primarily encountered in tropical regions, particularly:
- Central America
- Equatorial Africa
- India
Human infection is uncommon and generally occurs following environmental exposure.
Clinical Manifestations
Entomophthoromycosis Conidiobolae
The classic presentation is a slowly progressive granulomatous infection involving the nose, mouth, and surrounding facial tissues.
Patients may develop firm subcutaneous nodules and progressive swelling of the nasal and perinasal areas. Lesions can become extremely large and cause substantial facial disfigurement.
Rare manifestations include mediastinitis and pericarditis.
Diagnosis
Diagnosis is established by demonstrating fungal elements in a tissue biopsy and by obtaining a fungal culture.
Histopathologic examination is particularly useful when evaluating a chronic granulomatous facial mass.
Treatment
Because conidiobolomycosis is rare, evidence regarding optimal treatment is limited.
Saturated potassium iodide solution has traditionally been used for cutaneous and subcutaneous disease, either alone or with trimethoprim-sulfamethoxazole (TMP-SMX).
Azole antifungals such as fluconazole or ketoconazole have also historically been reported to produce improvement, particularly in more severe disease.
Large, persistent, or markedly disfiguring lesions may require surgical management, usually in conjunction with medical therapy.
High-Yield Clinical Pattern
Tropical exposure + slowly enlarging nodular nasal/perinasal mass + chronic granulomatous inflammation → consider Conidiobolus coronatus.
Key clinical pearl: Unlike rapidly invasive fungal infections, conidiobolomycosis classically produces a chronic, slowly progressive, disfiguring rhinofacial infection.
Infectious Disease and Microbiology – Coronavirus Group
Overview
Coronaviruses are enveloped, positive-sense single-stranded RNA viruses capable of causing respiratory and gastrointestinal disease. Human coronaviruses range from viruses producing mild common-cold syndromes to novel coronaviruses capable of causing severe systemic and lower respiratory tract disease.
Microbiologic Characteristics
Coronaviruses are:
- Single-stranded, positive-sense RNA viruses
- Enveloped viruses
Their surface spike glycoproteins produce the characteristic crown-like appearance responsible for the name coronavirus.
Incubation Period
For the common respiratory coronaviruses described in the source material, the incubation period is generally approximately 2–4 days.
Incubation periods vary among individual coronavirus species and syndromes.
Epidemiology
Human coronavirus infections occur worldwide.
Common human coronaviruses circulate widely and are frequent causes of respiratory infections. Transmission occurs predominantly through respiratory secretions and close contact.
Upper Respiratory Tract Infection
Common human coronaviruses frequently produce relatively mild respiratory illnesses resembling the common cold.
Clinical manifestations may include:
- Rhinorrhea
- Nasal congestion
- Sore throat
- Cough
- Headache
- Malaise
- Fever
They may also be associated with other upper respiratory manifestations, including sinusitis.
Lower Respiratory Tract Infection
Although uncommon with traditional common-cold coronaviruses, infection may occasionally progress to pneumonia in children or adults.
Lower respiratory disease is more clinically important in vulnerable populations and with the highly pathogenic novel coronaviruses.
Severe Acute Respiratory Syndrome (SARS)
A novel coronavirus was identified as the cause of severe acute respiratory syndrome (SARS).
SARS demonstrated that members of the coronavirus family can emerge from animal reservoirs and produce severe human respiratory disease with substantial outbreak potential.
Subsequent decades also saw the emergence of other clinically important coronaviruses, including the viruses responsible for MERS and COVID-19.
Gastrointestinal Disease
Coronaviruses may also be associated with gastrointestinal manifestations, including diarrhea. The degree of gastrointestinal involvement varies according to the particular coronavirus and clinical syndrome.
Diagnosis
Specific viral identification is generally unnecessary in routine uncomplicated common-cold illness, because the result usually does not change management.
When specific identification is clinically or epidemiologically important, diagnostic approaches can include:
PCR: Molecular detection is an important method for identifying specific coronaviruses.
Antigen detection: Viral antigens can be detected using appropriate assays for certain coronavirus infections.
Electron microscopy: Coronaviruses can be visualized directly by electron microscopy, although this is primarily a specialized or historical diagnostic technique rather than a routine clinical test.
Treatment
For uncomplicated infections caused by common respiratory coronaviruses, treatment is primarily symptomatic and supportive.
Management may include adequate hydration, rest, fever control, and symptomatic treatment of respiratory complaints.
Treatment of severe disease caused by specific emerging coronaviruses differs substantially and should not be generalized from treatment recommendations for common-cold coronaviruses.
Prevention
General respiratory infection prevention measures include reducing exposure to infected individuals, appropriate hand hygiene, respiratory hygiene, and improving ventilation in crowded indoor environments.
The older recommendation to simply avoid crowded places during winter months reflects the increased circulation of many respiratory viruses during colder seasons but is not a coronavirus-specific preventive strategy.
High-Yield Clinical Pattern
Enveloped virus + positive-sense single-stranded RNA + respiratory infection → think coronavirus.
Common human coronaviruses
→ Common cold / upper respiratory infection
Novel highly pathogenic coronaviruses
→ Potential severe lower respiratory disease and outbreaks
Exam Essentials
Family/group: Coronavirus
Genome: Positive-sense single-stranded RNA
Envelope: Present
Distribution: Worldwide
Common presentation: Upper respiratory tract infection/common cold
Other manifestations: Sinusitis, pneumonia, diarrhea
Historical severe syndrome: SARS
Diagnosis when indicated: PCR or antigen testing
Routine common cold: Specific coronavirus testing usually unnecessary
Treatment of uncomplicated common coronavirus infection: Supportive/symptomatic
Key clinical pearl: Coronaviruses are enveloped, positive-sense single-stranded RNA viruses whose clinical spectrum extends from the ordinary common cold to severe emerging respiratory syndromes.
Infectious Disease and Microbiology – Coronavirus Group Overview Coronaviruses are enveloped, positive-sense single-stranded RNA viruses capable of causing respiratory and gastrointestinal disease. Human coronaviruses range from viruses producing mild common-cold syndromes to novel coronaviruses capable of causing severe systemic and lower respiratory tract disease. Microbiologic Characteristics Coronaviruses are: Single-stranded, positive-sense RNA viruses Enveloped viruses Their surface spike glycoproteins produce the characteristic crown-like appearance responsible for the name coronavirus. Incubation Period For the common respiratory coronaviruses described in the source material, the incubation period is generally approximately 2–4 days. Incubation periods vary among individual coronavirus species and syndromes. Epidemiology Human coronavirus infections occur worldwide. Common human coronaviruses circulate widely and are frequent causes of respiratory infections. Transmission occurs predominantly through respiratory secretions and close contact. Upper Respiratory Tract Infection Common human coronaviruses frequently produce relatively mild respiratory illnesses resembling the common cold. Clinical manifestations may include: Rhinorrhea Nasal congestion Sore throat Cough Headache Malaise Fever They may also be associated with other upper respiratory manifestations, including sinusitis. Lower Respiratory Tract Infection Although uncommon with traditional common-cold coronaviruses, infection may occasionally progress to pneumonia in children or adults. Lower respiratory disease is more clinically important in vulnerable populations and with the highly pathogenic novel coronaviruses. Severe Acute Respiratory Syndrome (SARS) A novel coronavirus was identified as the cause of severe acute respiratory syndrome (SARS). SARS demonstrated that members of the coronavirus family can emerge from animal reservoirs and produce severe human respiratory disease with substantial outbreak potential. Subsequent decades also saw the emergence of other clinically important coronaviruses, including the viruses responsible for MERS and COVID-19. Gastrointestinal Disease Coronaviruses may also be associated with gastrointestinal manifestations, including diarrhea. The degree of gastrointestinal involvement varies according to the particular coronavirus and clinical syndrome. Diagnosis Specific viral identification is generally unnecessary in routine uncomplicated common-cold illness, because the result usually does not change management. When specific identification is clinically or epidemiologically important, diagnostic approaches can include: PCR: Molecular detection is an important method for identifying specific coronaviruses. Antigen detection: Viral antigens can be detected using appropriate assays for certain coronavirus infections. Electron microscopy: Coronaviruses can be visualized directly by electron microscopy, although this is primarily a specialized or historical diagnostic technique rather than a routine clinical test. Treatment For uncomplicated infections caused by common respiratory coronaviruses, treatment is primarily symptomatic and supportive. Management may include adequate hydration, rest, fever control, and symptomatic treatment of respiratory complaints. Treatment of severe disease caused by specific emerging coronaviruses differs substantially and should not be generalized from treatment recommendations for common-cold coronaviruses. Prevention General respiratory infection prevention measures include reducing exposure to infected individuals, appropriate hand hygiene, respiratory hygiene, and improving ventilation in crowded indoor environments. The older recommendation to simply avoid crowded places during winter months reflects the increased circulation of many respiratory viruses during colder seasons but is not a coronavirus-specific preventive strategy. High-Yield Clinical Pattern Enveloped virus + positive-sense single-stranded RNA + respiratory infection → think coronavirus. Common human coronaviruses
→ Common cold / upper respiratory infection Novel highly pathogenic coronaviruses
→ Potential severe lower respiratory disease and outbreaks Exam Essentials Family/group: Coronavirus
Genome: Positive-sense single-stranded RNA
Envelope: Present
Distribution: Worldwide
Common presentation: Upper respiratory tract infection/common cold
Other manifestations: Sinusitis, pneumonia, diarrhea
Historical severe syndrome: SARS
Diagnosis when indicated: PCR or antigen testing
Routine common cold: Specific coronavirus testing usually unnecessary
Treatment of uncomplicated common coronavirus infection: Supportive/symptomatic Key clinical pearl: Coronaviruses are enveloped, positive-sense single-stranded RNA viruses whose clinical spectrum extends from the ordinary common cold to severe emerging respiratory syndromes.